XML 47 R24.htm IDEA: XBRL DOCUMENT v3.25.0.1
Note 2 - Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2024
Notes Tables  
Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]

Exercise price per warrant

 $33.00 

Conversion rate - common shares per warrant

  1.50 

Closing price of common stock

 $23.72 

Volatility

  75%

Risk-free interest rate

  5.40%

Expected life of option (in years)

  0.3 

Dividend yield

 

zero

 
Schedule of Segment Reporting Information, by Segment [Table Text Block]
  

Years Ended December 31,

 
  

2024

  

2023

  

2022

 

Operating expenses

            

Research and development

 $69,637  $89,423  $68,032 

General and administrative

  71,809   16,534   11,988 

Other segment items(a)

  (117,104)  (8,740)  (3,774)

Net loss

 $24,342  $97,217  $76,246 
  

December 31,

 
  

2024

  

2023

 

Cash and cash equivalents

 $128,574  $121,136 
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
  

Years ended December 31,

 
  

2024

  

2023

  

2022

 

Numerator, basic:

            

Net loss

 $(24,342) $(97,217) $(76,246)

Denominator, basic:

            

Weighted average common shares outstanding

  46,329   41,932   40,202 

Net loss per share, basic

  (0.53)  (2.32)  (1.90)
             

Numerator, diluted:

            

Net loss

 $(24,342) $(97,217) $(76,246)

Adjustment for change in fair value of warrant liabilities

  (43,793)      

Adjusted numerator, diluted

 $(68,135) $(97,217) $(76,246)

Denominator, diluted:

            

Weighted average common shares outstanding

  46,329   41,932   40,202 

Dilutive effect of common stock warrants

  275       

Weighted average dilutive common shares

  46,604   41,932   40,202 

Net loss per share, diluted

 $(1.46) $(2.32) $(1.90)
             

Dilutive common stock options excluded from net loss per share, diluted

  3,154   2,123   2,055 

Dilutive Performance Awards excluded from loss per share, diluted

  7   7   7